IVERIC bio, Inc. Common Stock
ISEE
ISEE was delisted on the 10th of July, 2023.
71 hedge funds and large institutions have $58.3M invested in IVERIC bio, Inc. Common Stock in 2018 Q1 according to their latest regulatory filings, with 8 funds opening new positions, 19 increasing their positions, 24 reducing their positions, and 11 closing their positions.
40% more call options, than puts
Call options by funds: $129K | Put options by funds: $92K
5% less funds holding
Funds holding: 75 → 71 (-4)
14% less capital invested
Capital invested by funds: $68.1M → $58.3M (-$9.82M)
21% less repeat investments, than reductions
Existing positions increased: 19 | Existing positions reduced: 24
27% less first-time investments, than exits
New positions opened: 8 | Existing positions closed: 11
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AL
AJO LP
Philadelphia,
Pennsylvania
|
+$1.74M |
| 2 |
Acadian Asset Management
Boston,
Massachusetts
|
+$1.49M |
| 3 |
MERSOM
Municipal Employees' Retirement System of Michigan
Lansing,
Michigan
|
+$1.11M |
| 4 |
Dimensional Fund Advisors
Austin,
Texas
|
+$1.09M |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$820K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SCM
Stonepine Capital Management
Bend,
Oregon
|
-$2.19M |
| 2 |
Renaissance Technologies
New York
|
-$1.94M |
| 3 |
Millennium Management
New York
|
-$1.94M |
| 4 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
-$993K |
| 5 |
Morgan Stanley
New York
|
-$690K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
DTL
76
Dynamic Technology Lab
Singapore
| – | -$40K | -12,854 | Closed |
|
77
Squarepoint
New York
| – | -$31K | -10,014 | Closed |
|
|
TRCT
78
Tower Research Capital (TRC)
New York
| – | -$4K | -1,288 | Closed |
|
|
STA
79
Summit Trail Advisors
New York
| – | -$1K | -335 | Closed |
|
|
AG
80
Advisor Group
Phoenix,
Arizona
| – | +$6 | +2 | +1% |
|
|
S
81
SignatureFD
Atlanta,
Georgia
| – | +$96 | +33 | New |
|
ISEE Hedge Fund Activity: Q1 2018 in Review
71 of the 4,363 institutional investors tracked by Wall St. Rank reported a position in IVERIC bio, Inc. Common Stock (ISEE) for Q1 2018, worth a combined $58.3M — down 14% from $68.1M a quarter earlier.
Sellers outnumbered buyers: 11 funds closed out of ISEE and 8 opened new positions — a net loss of 3 holders — while 24 trimmed existing stakes and 19 added.
The largest buyer was AJO LP, adding an estimated $1.74M. The largest seller was Stonepine Capital Management, cutting an estimated $2.19M.
- 71 institutional investors held IVERIC bio, Inc. Common Stock (ISEE) as of Q1 2018, down from 75 in Q4 2017.
- Funds reported $58.3M of IVERIC bio, Inc. Common Stock stock for Q1 2018, down 14% quarter-over-quarter.
- 8 funds opened new IVERIC bio, Inc. Common Stock positions in Q1 2018 and 11 closed out, a net change of -3 holders.
- The largest IVERIC bio, Inc. Common Stock buyer in Q1 2018 was AJO LP, an estimated $1.74M added.
- The largest IVERIC bio, Inc. Common Stock seller in Q1 2018 was Stonepine Capital Management, an estimated $2.19M sold.
Based on aggregated 13F filings for Q1 2018.